AAAAAA

   
Results: 1-3 |
Results: 3
The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype
Authors: Zhang, XW Wong, R Hao, SX Pear, WS Ren, RB
Citation: Xw. Zhang et al., The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype, BLOOD, 97(1), 2001, pp. 277-287
Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder
Authors: Hao, SX Ren, RB
Citation: Sx. Hao et Rb. Ren, Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder, MOL CELL B, 20(4), 2000, pp. 1149-1161
Studies on microstructure of dodecylbetaine system with H-1 NMR and Raman method
Authors: Li, Y Li, GZ Hao, SX Li, LX
Citation: Y. Li et al., Studies on microstructure of dodecylbetaine system with H-1 NMR and Raman method, CHEM J CH U, 20(3), 1999, pp. 424-427
Risultati: 1-3 |